1. Home
  2. BGLC vs BRTX Comparison

BGLC vs BRTX Comparison

Compare BGLC & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$1.01

Market Cap

2.7M

Sector

Health Care

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

N/A

Current Price

$1.47

Market Cap

3.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGLC
BRTX
Founded
2017
1997
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical Specialities
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.1M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
BGLC
BRTX
Price
$1.01
$1.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.7K
★ 35.8K
Earning Date
11-13-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.78
N/A
EPS
N/A
★ N/A
Revenue
★ $7,424,911.00
$81,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$383.87
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.88
$0.14
52 Week High
$5.50
$30.17

Technical Indicators

Market Signals
Indicator
BGLC
BRTX
Relative Strength Index (RSI) 39.04 38.23
Support Level N/A $1.28
Resistance Level $1.39 $2.93
Average True Range (ATR) 0.05 0.15
MACD -0.02 0.04
Stochastic Oscillator 44.17 51.28

Price Performance

Historical Comparison
BGLC
BRTX

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: